Geneneer

1 known investors

GeneNeer develops next-generation gene-editing platforms that use RNA switches, molecular biology and AI to selectively silence genes and control their expression in crops, improving yield, resilience, shelf life and nutritional value. It licenses its Superlines, Mirtrons and TR8 regulation technologies to seed companies, researchers and growers in the agritech industry.